Event-Driven Stocks

XOMA Royalty Corp

XOMANasdaq

Healthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 1 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$10.3M$6.7M$2.6M$4.2M$36.5M$27.9M
Operating income$11.4M−$40.0M−$41.8M−$17.4M$17.5M$12.4M
Net income$31.7M−$13.8M−$40.8M−$17.1M$15.8M$13.3M
Total assets$272.7M$221.3M$234.3M$140.4M$166.6M$125.3M
Total liabilities$168.7M$139.4M$145.6M$16.4M$24.7M$38.9M
Equity$83.9M$81.9M$88.7M$124.0M$141.9M$86.4M
EPS (diluted)$1.46$-1.65$-4.04$-1.98$0.65$0.78
Shares out.12.0M11.6M11.5M11.3M11.2M9.8M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
110.0%
Net margin
306.4%
Return on equity
37.8%
Return on assets
11.6%
Return on capital (ROCE)
4.8%
Liabilities / assets
61.9%
Debt / equity
2.01×
Book value / share
$7.01
Revenue growth (YoY)
55.6%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-11.82distress
Accruals / assets
10.6%high accruals
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
63
/ 100
Profitability 100Growth 100Catalyst 33Earnings quality 33Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 1 warning● 4 good
  • Altman Z″ in the distress zone
  • High accruals — earnings-quality risk
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Positive operating cash flow

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026786,7794.8-6.4%
Apr 30, 2026840,9521.5-31.5%
Apr 15, 20261.2M7.4-12.2%
Mar 31, 20261.4M13.6+2.7%
Mar 13, 20261.4M9.6-1.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (6)